Sarepta Therapeutics has a total of 1880 patents globally, out of which 812 have been granted. Of these 1880 patents, more than 63% patents are active. The United States of America is where Sarepta Therapeutics has filed the maximum number of patents, followed by Japan and Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Sarepta Therapeutics.
Sarepta Therapeutics was founded in 1980. Sarepta Therapeutics is a biotech company that develops medicines for rare, infectious, and other serious diseases. It focuses on quickly developing new drugs using its own RNA-based technologies. The company relies on third-party manufacturers to produce its drug candidates, most of which are still in early stages of development.
Do read about some of the most popular patents of Sarepta Therapeutics which have been covered by us in this article and also you can find Sarepta Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Sarepta Therapeutics patent portfolio.
How many patents does Sarepta Therapeutics have?
Sarepta Therapeutics has a total of 1880 patents globally. These patents belong to 137 unique patent families. Out of 1880 patents, 1189 patents are active.
How Many Patents did Sarepta Therapeutics File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Sarepta Therapeutics Applications Filed | Sarepta Therapeutics Patents Granted |
| 2025 | 33 | 73 |
| 2024 | 99 | 72 |
| 2023 | 88 | 80 |
| 2022 | 81 | 105 |
| 2021 | 114 | 71 |
| 2020 | 103 | 59 |
| 2019 | 138 | 64 |
| 2018 | 125 | 74 |
| 2017 | 307 | 46 |
| 2016 | 116 | 46 |
How many Sarepta Therapeutics patents are Alive/Dead?
Worldwide Patents

How Many Patents did Sarepta Therapeutics File in Different Countries?

Countries in which Sarepta Therapeutics Filed Patents
| Country | Patents |
| United States of America | 282 |
| Japan | 171 |
| Europe (EPO) | 133 |
| Australia | 122 |
| Korea (South) | 89 |
| Hong Kong (S.A.R.) | 80 |
| Canada | 77 |
| Israel | 76 |
| China | 62 |
| Brazil | 55 |
| Mexico | 49 |
| India | 48 |
| Taiwan | 47 |
| Germany | 45 |
| New Zealand | 36 |
| Singapore | 35 |
| Austria | 34 |
| Eurasia | 30 |
| Spain | 27 |
| Colombia | 25 |
| Italy | 24 |
| Saudi Arabia | 23 |
| Argentina | 23 |
| Malaysia | 15 |
| Denmark | 14 |
| Norway | 11 |
| Croatia | 11 |
| South Africa | 11 |
| Slovenia | 10 |
| Chile | 10 |
| Lithuania | 10 |
| Hungary | 10 |
| Macao | 9 |
| Poland | 9 |
| Malta | 8 |
| Portugal | 8 |
| Serbia | 7 |
| Republic of Moldova | 6 |
| Tunisia | 6 |
| Morocco | 6 |
| Cyprus | 5 |
| Slovakia | 5 |
| Finland | 4 |
| Albania | 4 |
| Thailand | 3 |
| Turkey | 3 |
| Estonia | 3 |
| Russia | 2 |
| United Arab Emirates | 1 |
Where are Research Centers of Sarepta Therapeutics Patents Located?

10 Best Sarepta Therapeutics Patents
US20100016215A1 is the most popular patent in the Sarepta Therapeutics portfolio. It has received 298 citations so far from companies like Airware, Alethia Biotherapeutics, Philips.
Below is the list of 10 most cited patents of Sarepta Therapeutics:
| Publication Number | Citation Count |
| US20100016215A1 | 298 |
| WO2012150960A1 | 280 |
| US8076476B2 | 196 |
| US8299206B2 | 183 |
| US7468418B2 | 176 |
| WO2016187425A1 | 157 |
| US6841542B2 | 153 |
| US7094765B1 | 137 |
| US7049431B2 | 118 |
| WO2014100714A1 | 103 |
What Percentage of Sarepta Therapeutics US Patent Applications were Granted?
Sarepta Therapeutics (Excluding its subsidiaries) has filed 243 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 143 have been granted leading to a grant rate of 67.77%.
Below are the key stats of Sarepta Therapeutics patent prosecution at the USPTO.

Which Law Firms are managing US Patents for Sarepta Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Sterne Kessler Goldstein & Fox PLLC | 106 | 41.98% |
| Lathrop Gpm Llp | 65 | 93.11% |
| Sarepta Therapeutics Inc (Inhouse IP Dept) | 46 | 95.65% |
| Seed Intellectual Property Law Group Llp | 11 | 63.64% |
| Snell & Wilmer LLP | 8 | 14.29% |
| Finnegan | 2 | 100.00% |
| Birch Stewart Kolasch & Birch Llp | 1 | 100.00% |
| Cooley Llp | 1 | 0% |
| Foley & Lardner Llp | 1 | 0% |
| Invista Kilpatrick Townsend & Stockton Llp | 1 | 100.00% |
What are Sarepta Therapeutics key innovation segments?
What Technologies are Covered by Sarepta Therapeutics?

The chart below distributes patents filed by Sarepta Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Sarepta Therapeutics thinks it’s important to protect particular technological inventions.

R&D Focus: How has Sarepta Therapeutics Solar search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Sarepta Therapeutics?